Immunological alterations in hepatitis C virus infection

World Journal of Gastroenterology

Volumn 19, Issue 47, 2013, Pages 8916-8923

  Calvaruso, Vincenza ^a   Craxì, Antonio ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Autoantibody; Cyto penia; Extrahepatic manifestation; Hepatitis C virus; Immune disorders

Indexed keywords

CHEMOKINE RECEPTOR CCR10; CRYOGLOBULIN; GAMMA INTERFERON; RHEUMATOID FACTOR; THYROID PEROXIDASE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; AUTOIMMUNE HEPATITIS; CARDIOMYOPATHY; COOMBS TEST; CRYOGLOBULINEMIA; CYTOPENIA; DIABETES MELLITUS; ECHOGRAPHY; GENE EXPRESSION; HEMOLYTIC ANEMIA; HEPATITIS C; HUMAN; HYPOCOMPLEMENTEMIA; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNE RESPONSE; PATHOGENESIS; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; THROMBOCYTOPENIA; THYROID DISEASE;

AUTOANTIBODY; CYTOPENIA; EXTRAHEPATIC MANIFESTATION; HEPATITIS C VIRUS; IMMUNE DISORDERS;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS;

EID: 84890959052     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i47.8916     Document Type: Article

References (82)

1. Zignego AL, Macchia D, Monti M, Thiers V, Mazzetti M, Foschi M, Maggi E, Romagnani S, Gentilini P, Bréchot C. Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol 1992; 15: 382-386 [PMID: 1332999 DOI: 10.1016/0168-8278(92)90073-X]
2. Ferri C, Monti M, La Civita L, Longombardo G, Greco F, Pasero G, Gentilini P, Bombardieri S, Zignego AL. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood 1993; 82: 3701-3704 [PMID: 8260706]
3. Ferri C, Mascia MT. Cryoglobulinemic vasculitis. Curr Opin Rheumatol 2006; 18: 54-63 [PMID: 16344620]
4. Ferri C, Antonelli A, Mascia MT, Sebastiani M, Fallahi P, Ferrari D, Giunti M, Pileri SA, Zignego AL. B-cells and mixed cryoglobulinemia. Autoimmun Rev 2007; 7: 114-120 [PMID: 18035320 DOI: 10.1016/j.autrev.2007.02.019]
5. Sansonno D, Carbone A, De Re V, Dammacco F. Hepatitis C virus infection, cryoglobulinaemia, and beyond. Rheumatology (Oxford) 2007; 46: 572-578 [PMID: 17317717 DOI: 10.1093/ rheumatology/kel425]
6. Ferri C, Antonelli A, Mascia MT, Sebastiani M, Fallahi P, Ferrari D, Pileri SA, Zignego AL. HCV-related autoimmune and neoplastic disorders: the HCV syndrome. Dig Liver Dis 2007; 39 Suppl 1: S13-S21 [PMID: 17936215 DOI: 10.1016/ S1590-8658(07)80005-3]
7. Zignego AL, Ferri C, Pileri SA, Caini P, Bianchi FB. Ex-trahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach. Dig Liver Dis 2007; 39: 2-17 [PMID: 16884964 DOI: 10.1016/ j.dld.2006.06.008]
8. Ferri C, Sebastiani M, Giuggioli D, Cazzato M, Longombardo G, Antonelli A, Puccini R, Michelassi C, Zignego AL. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum 2004; 33: 355-374 [PMID: 15190522 DOI: 10.1016/j.semarthrit.2003.1 0.001]
9. Ferri C, Zignego AL, Pileri SA. Cryoglobulins. J Clin Pathol 2002; 55: 4-13 [PMID: 11825916 DOI: 10.1136/jcp.55.1.4]
10. Rosa D, Saletti G, De Gregorio E, Zorat F, Comar C, D'Oro U, Nuti S, Houghton M, Barnaba V, Pozzato G, Abrignani S. Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. Proc Natl Acad Sci USA 2005; 102: 18544-18549 [PMID: 16339892 DOI: 10.1073/pnas.0509402102]
11. Antonelli A, Ferri C, Ferrari SM, Colaci M, Fallahi P. Im-munopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia. Autoim-mun Rev 2008; 8: 18-23 [PMID: 18708169 DOI: 10.1016/ j.autrev.2008.07.017]
12. Patzwahl R, Meier V, Ramadori G, Mihm S. Enhanced expression of interferon-regulated genes in the liver of patients with chronic hepatitis C virus infection: detection by sup-pression-subtractive hybridization. J Virol 2001; 75: 1332-1338 [PMID: 11152506 DOI: 10.1128/JVI.75.3.1332-1338.2001]
13. Zignego AL. Enhanced TH1 cytokine production in hepatitis C virus-infected patients with mixed cryoglobulinemia: understanding the pathological issues. J Hepatol 2004; 41: 1045-1049 [PMID: 15582141 DOI: 10.1016/j.jhep.2004.10.007]
14. Antonelli A, Rotondi M, Fallahi P, Romagnani P, Ferrari SM, Buonamano A, Ferrannini E, Serio M. High levels of circulating CXC chemokine ligand 10 are associated with chronic autoimmune thyroiditis and hypothyroidism. J Clin Endocri-nol Metab 2004; 89: 5496-5499 [PMID: 15531503 DOI: 10.1210/ jc.2004-0977]
15. Matskevich AA, Strayer DS. Exploiting hepatitis C virus activation of NFkappaB to deliver HCV-responsive expression of interferons alpha and gamma. Gene Ther 2003; 10: 1861-1873 [PMID: 14502215 DOI: 10.1038/sj.gt.3302091]
16. Murata M, Nabeshima S, Maeda N, Nakashima H, Kashi-wagi S, Hayashi J. Increased frequency of IFN-gamma-pro-ducing peripheral CD8+ T cells with memory-phenotype in patients with chronic hepatitis C. J Med Virol 2002; 67: 162-170 [PMID: 11992577 DOI: 10.1002/jmv.2205]
17. Itoh Y, Morita A, Nishioji K, Narumi S, Toyama T, Daimon Y, Nakamura H, Kirishima T, Okanoue T. Clinical signifcance of elevated serum interferon- inducible protein-10 levels in hepatitis C virus carriers with persistently normal serum transaminase levels. J Viral Hepat 2001; 8: 341-348 [PMID: 11555191 DOI: 10.1046/j.1365-2893.2001.00309.x]
18. Shields PL, Morland CM, Salmon M, Qin S, Hubscher SG, Adams DH. Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. J Immunol 1999; 163: 6236-6243 [PMID: 10570316]
19. Apolinario A, Majano PL, Lorente R, Núñez O, Clemente G, García-Monzón C. Gene expression profle of T-cell-specifc chemokines in human hepatocyte-derived cells: evidence for a synergistic inducer effect of cytokines and hepatitis C virus proteins. J Viral Hepat 2005; 12: 27-37 [PMID: 15655045 DOI: 10.1111/j.1365-2893.2005.00540.x]
20. Ferri C, Greco F, Longombardo G, Palla P, Moretti A, Marzo E, Mazzoni A, Pasero G, Bombardieri S, Highfeld P. Association between hepatitis C virus and mixed cryoglobulinemia [see comment]. Clin Exp Rheumatol 1991; 9: 621-624 [PMID: 1662567]
21. Antonelli A, Ferri C, Pampana A, Fallahi P, Nesti C, Pasquini M, Marchi S, Ferrannini E. Thyroid disorders in chronic hepatitis C. Am J Med 2004; 117: 10-13 [PMID: 15210382 DOI: 10.1016/j.amjmed.2004.01.023]
22. Antonelli A, Ferri C, Fallahi P, Pampana A, Ferrari SM, Goglia F, Ferrannini E. Hepatitis C virus infection: evidence for an association with type 2 diabetes. Diabetes Care 2005; 28: 2548-2550 [PMID: 16186298 DOI: 10.2337/diacare.28.10.2548]
23. Leone N, Pellicano R, Ariata Maiocco I, Modena V, Marietti G, Rizzetto M, Ponzetto A. Mixed cryoglobulinaemia and chronic hepatitis C virus infection: the rheumatic manifestations. J Med Virol 2002; 66: 200-203 [PMID: 11782928 DOI: 10.1002/jmv.2130]
24. Wener MH, Hutchinson K, Morishima C, Gretch DR. Absence of antibodies to cyclic citrullinated peptide in sera of patients with hepatitis C virus infection and cryoglobuline-mia. Arthritis Rheum 2004; 50: 2305-2308 [PMID: 15248231 DOI: 10.1002/art.20355]
25. Haddad J, Deny P, Munz-Gotheil C, Ambrosini JC, Trinchet JC, Pateron D, Mal F, Callard P, Beaugrand M. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992; 339: 321-323 [PMID: 1346409 DOI: 10.1016/0140-6736(92)91645-O]
26. Koike K, Moriya K, Ishibashi K, Yotsuyanagi H, Shintani Y, Fujie H, Kurokawa K, Matsuura Y, Miyamura T. Sialad-enitis histologically resembling Sjogren syndrome in mice transgenic for hepatitis C virus envelope genes. Proc Natl Acad Sci USA 1997; 94: 233-236 [PMID: 8990191 DOI: 10.1073/ pnas.94.1.233]
27. Ramos-Casals M, Loustaud-Ratti V, De Vita S, Zeher M, Bosch JA, Toussirot E, Medina F, Rosas J, Anaya JM, Font J. Sjögren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases. Medicine (Baltimore) 2005; 84: 81-89 [PMID: 15758837 DOI: 10.1097/01. md.0000157397.30055.c9]
28. Ramos-Casals M, García-Carrasco M, Cervera R, Rosas J, Trejo O, de la Red G, Sánchez-Tapias JM, Font J, Ingelmo M. Hepatitis C virus infection mimicking primary Sjögren syndrome. A clinical and immunologic description of 35 cases. Medicine (Baltimore) 2001; 80: 1-8 [PMID: 11204499 DOI: 10.1097/00005792-200101000-00001]
29. Scott CA, Avellini C, Desinan L, Pirisi M, Ferraccioli GF, Bardus P, Fabris C, Casatta L, Bartoli E, Beltrami CA. Chronic lymphocytic sialoadenitis in HCV-related chronic liver disease: comparison of Sjögren's syndrome. Histopathology 1997; 30: 41-48 [PMID: 9023556 DOI: 10.1046/j.1365-2559.1997. d01-561.x]
30. De Vita S, Sacco C, Sansonno D, Gloghini A, Dammacco F, Crovatto M, Santini G, Dolcetti R, Boiocchi M, Carbone A, Zagonel V. Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection. Blood 1997; 90: 776-782 [PMID: 9226178]
31. Okabe M, Fukuda K, Arakawa K, Kikuchi M. Chronic variant of myocarditis associated with hepatitis C virus infection. Circulation 1997; 96: 22-24 [PMID: 9236410 DOI: 10.1161/01. CIR.96.1.22]
32. Frustaci A, Calabrese F, Chimenti C, Pieroni M, Thiene G, Maseri A. Lone hepatitis C virus myocarditis responsive to immunosuppressive therapy. Chest 2002; 122: 1348-1356 [PMID: 12377863 DOI: 10.1378/chest.122.4.1348]
33. Matsumori A, Yutani C, Ikeda Y, Kawai S, Sasayama S. Hepatitis C virus from the hearts of patients with myocarditis and cardiomyopathy. Lab Invest 2000; 80: 1137-1142 [PMID: 10908160 DOI: 10.1038/labinvest.3780120]
34. Matsumori A, Shimada T, Chapman NM, Tracy SM, Mason JW. Myocarditis and heart failure associated with hepatitis C virus infection. J Card Fail 2006; 12: 293-298 [PMID: 16679263 DOI: 10.1016/j.cardfail.2005.11.004]
35. Antonelli A, Ferri C, Ferrari SM, Colaci M, Sebastiani M, Zig-nego AL, Ghiri E, Goglia F, Fallahi P. High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C. J Viral Hepat 2010; 17: 851-853 [PMID: 20002300 DOI: 10.1111/j.1365-2893.2009.01237.x]
36. Antonelli A, Ferri C, Ferrari SM, Marchi S, De Bortoli N, Sansonno D, Chiavacci C, Ferrannini E, Fallahi P. N-terminal pro-brain natriuretic peptide and tumor necrosis factor-alpha both are increased in patients with Hepatitis C. J Interferon Cytokine Res 2010; 30: 359-363 [PMID: 20187770 DOI: 10.1089/ jir.2009.0059]
37. Dela Serna Higuera C, Bárcena-Marugán R, Sanz de Villalo bos E. Hemolytic anemia secondary to alpha-interferon treatment in a patient with chronic C hepatitis. J Clin Gastroenterol 1999; 28: 358-359 [PMID: 10372938 DOI: 10.1097/00004836-19 9906000-00017]
38. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol 2011; 55: 245-264 [PMID: 21371579 DOI: 10.1016/j.jhep.2011.02.023]
39. Hyman GA, Southworth H. Hemolytic anemia associated with liver disease. Am J Med Sci 1951; 221: 448-456 [PMID: 14819022 DOI: 10.1097/00000441-195104000-00014]
40. Panush RS, Wilkinson LS, Fagin RR. Chronic active hepatitis associated with eosinophilia and Coombs'-positive hemolytic anemia. Gastroenterology 1973; 64: 1015-1019 [PMID: 4700414]
41. Portell A, Pedreira JD, Richart C, Vargas V, Martín C, Guardia J. Autoimmune hemolytic anemia associated with chronic liver disease. Rev Clin Esp 1982; 164: 101-103 [PMID: 7089320]
42. Srinivasan R. Autoimmune hemolytic anemia in treatment-naïve chronic hepatitis C infection. J Clin Gastroenterol 2001; 32: 245-247 [PMID: 11246355 DOI: 10.1097/00004836-2001030 00-00015]
43. Chao TC, Chen CY, Yang YH, Chen PM, Chang FY, Lee SD. Chronic hepatitis C virus infection associated with primary warm-type autoimmune hemolytic anemia. J Clin Gastroen-terol 2001; 33: 232-233 [PMID: 11500615 DOI: 10.1097/0000483 6-200109000-00014]
44. Ramos-Casals M, García-Carrasco M, López-Medrano F, Trejo O, Forns X, López-Guillermo A, Muñoz C, Ingelmo M, Font J. Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 35 cases. Medicine (Baltimore) 2003; 82: 87-96 [PMID: 12640185 DOI: 10.1097/00005792-200303000-00003]
45. Nagamine T, Ohtuka T, Takehara K, Arai T, Takagi H, Mori M. Thrombocytopenia associated with hepatitis C viral infection. J Hepatol 1996; 24: 135-140 [PMID: 8907565 DOI: 10.1016/ S0168-8278(96)80021-3]
46. Hernández F, Blanquer A, Linares M, López A, Tarín F, Cerveró A. Autoimmune thrombocytopenia associated with hepatitis C virus infection. Acta Haematol 1998; 99: 217-220 [PMID: 9644300 DOI: 10.1159/000040842]
47. Linares M, Pastor E, Hernández F, Montagud M, Blanquer A. Autoimmune thrombocytopenia and hepatitis C virus infection. Am J Hematol 1996; 53: 284 [PMID: 8948679]
48. Pivetti S, Novarino A, Merico F, Bertero MT, Brunetto MR, Bonino F, Caligaris-Cappio F. High prevalence of autoimmune phenomena in hepatitis C virus antibody positive patients with lymphoproliferative and connective tissue disorders. Br J Haematol 1996; 95: 204-211 [PMID: 8857962 DOI: 10.1046/j.1365-2141.1996.7542376.x]
49. Hamaia S, Li C, Allain JP. The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines. Blood 2001; 98: 2293-2300 [PMID: 11588022 DOI: 10.1182/blood. V98.8.2293]
50. Pockros PJ, Duchini A, McMillan R, Nyberg LM, McHutchi-son J, Viernes E. Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection. Am J Gas-troenterol 2002; 97: 2040-2045 [PMID: 12190174 DOI: 10.1111/ j.1572-0241.2002.05845.x]
51. Rajan S, Liebman HA. Treatment of hepatitis C related thrombocytopenia with interferon alpha. Am J Hematol 2001; 68: 202-209 [PMID: 11754404 DOI: 10.1002/ajh.1180]
52. Panzer S, Seel E, Brunner M, Körmöczi GF, Schmid M, Fe-renci P, Peck-Radosavljevic M. Platelet autoantibodies are common in hepatitis C infection, irrespective of the presence of thrombocytopenia. Eur J Haematol 2006; 77: 513-517 [PMID: 17042765 DOI: 10.1111/j.0902-4441.2006.t01-1-EJH2888.x]
53. García-Suárez J, Burgaleta C, Hernanz N, Albarran F, Toba-ruela P, Alvarez-Mon M. HCV-associated thrombocytopenia: clinical characteristics and platelet response after recombi-nant alpha2b-interferon therapy. Br J Haematol 2000; 110: 98-103 [PMID: 10930984 DOI: 10.1046/j.1365-2141.2000.02132. x]
54. Rajan SK, Espina BM, Liebman HA. Hepatitis C virus-related thrombocytopenia: clinical and laboratory characteristics compared with chronic immune thrombocytopenic pur-pura. Br J Haematol 2005; 129: 818-824 [PMID: 15953010 DOI: 10.1111/j.1365-2141.2005.05542.x]
55. Zhang L, Li H, Zhao H, Ji L, Yang R. Hepatitis C virus-related adult chronic idiopathic thrombocytopenic pur-pura: experience from a single Chinese center. Eur J Haematol 2003; 70: 196-197 [PMID: 12605667 DOI: 10.1034/ j.1600-0609.2003.00032.x]
56. Pawlotsky JM, Bouvier M, Fromont P, Deforges L, Duval J, Dhumeaux D, Bierling P. Hepatitis C virus infection and autoimmune thrombocytopenic purpura. J Hepatol 1995; 23: 635-639 [PMID: 8750160 DOI: 10.1016/0168-8278(95)80027-1]
57. Sakuraya M, Murakami H, Uchiumi H, Hatsumi N, Akiba T, Yokohama A, Matsushima T, Tsukamoto N, Morita K, Kara-sawa M, Ogawara H, Nojima Y. Steroid-refractory chronic idiopathic thrombocytopenic purpura associated with hepatitis C virus infection. Eur J Haematol 2002; 68: 49-53 [PMID: 11952821 DOI: 10.1034/j.1600-0609.2002.00509.x]
58. Fernandez-Soto L, Gonzalez A, Escobar-Jimenez F, Vazquez R, Ocete E, Olea N, Salmeron J. Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy. Arch Intern Med 1998; 158: 1445-1448 [PMID: 9665354 DOI: 10.1001/ archinte.158.13.1445]
59. Marazuela M, García-Buey L, González-Fernández B, García-Monzón C, Arranz A, Borque MJ, Moreno-Otero R. Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy. Clin Endocri-nol (Oxf) 1996; 44: 635-642 [PMID: 8759175 DOI: 10.1046/ j.1365-2265.1996.751768.x]
60. Deutsch M, Dourakis S, Manesis EK, Gioustozi A, Hess G, Horsch A, Hadziyannis S. Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy. Hepatology 1997; 26: 206-210 [PMID: 9214471 DOI: 10.1002/hep.510260127]
61. Huang MJ, Wu SS, Liaw YF. Thyroid abnormalities in patients with chronic viral hepatitis. Hepatology 1994; 20: 1651-1652 [PMID: 7982669 DOI: 10.1002/hep.1840200650]
62. Ganne-Carrie N, Medini A, Coderc E, Seror O, Christidis C, Grimbert S, Trinchet JC, Beaugrand M. Latent autoimmune thyroiditis in untreated patients with HCV chronic hepatitis: a case-control study. J Autoimmun 2000; 14: 189-193 [PMID: 10677250 DOI: 10.1006/jaut.1999.0360]
63. Preziati D, La Rosa L, Covini G, Marcelli R, Rescalli S, Per-sani L, Del Ninno E, Meroni PL, Colombo M, Beck-Peccoz P. Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a. Eur J Endocrinol 1995; 132: 587-593 [PMID: 7749499 DOI: 10.1530/eje.0.1320587]
64. Quaranta JF, Tran A, Régnier D, Letestu R, Beusnel C, Fuzi-bet JG, Thiers V, Rampal P. High prevalence of antibodies to hepatitis C virus (HCV) in patients with anti-thyroid autoan-tibodies. J Hepatol 1993; 18: 136-138 [PMID: 7688009]
65. Lenzi M, Johnson PJ, McFarlane IG, Ballardini G, Smith HM, McFarlane BM, Bridger C, Vergani D, Bianchi FB, Williams R. Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity. Lancet 1991; 338: 277-280 [PMID: 1677111 DOI: 10.1016/0140-6736(91)90418-O]
66. Minelli R, Braverman LE, Giuberti T, Schianchi C, Gardini E, Salvi M, Fiaccadori F, Ugolotti G, Roti E. Effects of excess iodine administration on thyroid function in euthyroid patients with a previous episode of thyroid dysfunction induced by interferon-alpha treatment. Clin Endocrinol (Oxf) 1997; 47: 357-361 [PMID: 9373459 DOI: 10.1046/ j.1365-2265.1997.2721081.x]
67. Cacoub P, Poynard T, Ghillani P, Charlotte F, Olivi M, Piette JC, Opolon P. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum 1999; 42: 2204-2212 [PMID: 10524695]
68. Antonelli A, Ferri C, Fallahi P, Giuggioli D, Nesti C, Lon-gombardo G, Fadda P, Pampana A, Maccheroni M, Ferran-nini E. Thyroid involvement in patients with overt HCV-related mixed cryoglobulinaemia. QJM 2004; 97: 499-506 [PMID: 15256607 DOI: 10.1093/qjmed/hch088]
69. Antonelli A, Ferri C, Fallahi P, Ferrari SM, Ghinoi A, Rotondi M, Ferrannini E. Thyroid disorders in chronic hepatitis C virus infection. Thyroid 2006; 16: 563-572 [PMID: 16839258 DOI: 10.1089/thy.2006.16.563]
70. Antonelli A, Ferri C, Fallahi P, Nesti C, Zignego AL, Macche-roni M. Thyroid cancer in HCV-related mixed cryoglobuli-nemia patients. Clin Exp Rheumatol 2002; 20: 693-696 [PMID: 12412202]
71. Antonelli A, Ferri C, Fallahi P, Pampana A, Ferrari SM, Ba-rani L, Marchi S, Ferrannini E. Thyroid cancer in HCV-related chronic hepatitis patients: a case-control study. Thyroid 2007; 17: 447-451 [PMID: 17542674 DOI: 10.1089/thy.2006.0194]
72. Caronia S, Taylor K, Pagliaro L, Carr C, Palazzo U, Petrik J, O' Rahilly S, Shore S, Tom BD, Alexander GJ. Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatol-ogy 1999; 30: 1059-1063 [PMID: 10498660 DOI: 10.1002/ hep.510300416]
73. Mason A. Viral induction of type 2 diabetes and autoimmune liver disease. J Nutr 2001; 131: 2805S-2808S [PMID: 11584111]
74. Petta S. Insulin resistance and diabetes mellitus in patients with chronic hepatitis C: spectators or actors? Dig Liver Dis 2012; 44: 359-360 [PMID: 22418268 DOI: 10.1016/ j.dld.2012.02.001]
75. Antonelli A, Ferri C, Fallahi P, Sebastiani M, Nesti C, Barani L, Barale R, Ferrannini E. Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients. Rheumatology (Oxford) 2004; 43: 238-240 [PMID: 13130149 DOI: 10.1093/rheumatol-ogy/keh011]
76. Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000; 133: 592-599 [PMID: 11033586 DOI: 10.7326/0003-4819-133-8-200010170-00009]
77. Noto H, Raskin P. Hepatitis C infection and diabetes. J Diabetes Complications 2006; 20: 113-120 [PMID: 16504840 DOI: 10.1016/j.jdiacomp.2006.01.001]
78. Mason AL, Lau JY, Hoang N, Qian K, Alexander GJ, Xu L, Guo L, Jacob S, Regenstein FG, Zimmerman R, Everhart JE, Wasserfall C, Maclaren NK, Perrillo RP. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 29: 328-333 [PMID: 9918906 DOI: 10.1002/ hep.510290235]
79. Petit JM, Bour JB, Galland-Jos C, Minello A, Verges B, Guiguet M, Brun JM, Hillon P. Risk factors for diabetes melli-tus and early insulin resistance in chronic hepatitis C. J Hepa-tol 2001; 35: 279-283 [PMID: 11580152 DOI: 10.1016/S0168-8278(01)00143-X]
80. Betterle C, Fabris P, Zanchetta R, Pedini B, Tositti G, Bosi E, de Lalla F. Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection. Diabetes Care 2000; 23: 1177-1181 [PMID: 10937518 DOI: 10.2337/diacare.23.8.1177]
81. Piquer S, Hernández C, Enriquez J, Ross A, Esteban JI, Genescà J, Bonifacio E, Puig-Domingo M, Simó R. Islet cell and thyroid antibody prevalence in patients with hepatitis C virus infection: effect of treatment with interferon. J Lab Clin Med 2001; 137: 38-42 [PMID: 11150022 DOI: 10.1067/ mlc.2001.111515]
82. Bosi E, Minelli R, Bazzigaluppi E, Salvi M. Fulminant autoimmune Type 1 diabetes during interferon-alpha therapy: a case of Th1-mediated disease? Diabet Med 2001; 18: 329-332 [PMID: 11437866 DOI: 10.1046/j.1464-5491.2001.00492.x]